Narrow band imaging for bladder cancer

doi:10.1016/j.ajur.2016.05.001

Asian Journal of Urology, 2016, 3 (3): 126-129 doi: 10.1016/j.ajur.2016.05.001

Review

Current Issue | Archive | Adv Search

Narrow band imaging for bladder cancer

Thomas Y. Hsueh^a,b, Allen W. Chiu^a,b

a Division of Urology, Department of Surgery, Taipei City Hospital Renai Branch, Taipei;
b Department of Urology, School of Medicine, National Yang-Ming University, Taipei

Abstract
Related Citation (9)

Download:

HTML

PDF (393KB)
Export: BibTeX | EndNote (RIS)

Abstract Narrow band imaging (NBI) is a newly developed technology aiming to provide additional endoscopic information for patients with bladder cancer. This review focuses on the diagnostic accuracy and treatment outcome using NBI cystoscopy for the treatment of nonmuscle invasive bladder cancer. Current results showed improved sensitivity of NBI cystoscopy compared to conventional white light cystoscopy, although lower specificity and increased false-positive results were reported using NBI cystoscopy. The treatment outcome using NBI technology in transurethral resection of bladder tumor had a positive impact while decreased number of residual tumors and tumor recurrence at follow-up were reported. In the future, the application of NBI technology might refine the treatment and follow-up protocol in patients with non-muscle invasive bladder cancer. However, this large scale prospective studies are required to confirm the real cost-effectiveness of this new technology.

Key words： Non-muscle invasive bladder cancer Narrow band imaging Diagnosis Treatment

Received: 02 March 2016 Published: 05 July 2016

Corresponding Authors: Allen W. Chiu E-mail: whchiu1216@gamil.com

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	Articles by authors
	Thomas Y. Hsueh
	Allen W. Chiu

TRENDMD:

Cite this article:

Thomas Y. Hsueh,Allen W. Chiu. Narrow band imaging for bladder cancer[J]. Asian Journal of Urology, 2016, 3(3): 126-129.

URL:

http://www.ajurology.com/EN/10.1016/j.ajur.2016.05.001 OR http://www.ajurology.com/EN/Y2016/V3/I3/126

[1]	DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252-71.
[2]	Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compe′rat E, et al. EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013;64:639-53.
[3]	Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. Eur Urol 2013;63:4-15.
[4]	Henry NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
[5]	Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982;127:250-2.
[6]	Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, et al. Grading and staging of bladder carcinoma in transurethral resection specimens.Correlationwith105matched cystectomy specimens. Am J Clin Pathol 2000;113:275-9.
[7]	Liu JJ, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: considerations and perspectives. J Urol 2012;188:361-8.
[8]	BUS MT, de Bruin DM, Faber DJ, Kamphuis GM, Zondervan PJ, Laguna Pes MP, et al. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. J Endourol 2015;29:113-23.
[9]	Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 2004;59: 288-95.
[10]	Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H. Magnifying endoscopy combined with narrow band imaging systemfor early gastric cancer: correlation of vascular patternwith histopathology (including video). Endoscopy 2004;36:1080-4.
[11]	East JE, Suzuki N, von Herbay A, Saunders BP. Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses. Gut 2006;55:1432-5.
[12]	Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008;101:702-6.
[13]	Bryan RT, Shah ZH, Collins SI, Wallace DM. Narrow-band imaging flexible cystoscopy: a new user's experience. J Endourol 2010;24:1339-43.
[14]	Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S. Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 2010;24:1807-11.
[15]	Geavlete B, Multescu R, Georgescu D, Stănescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumorseresults of a prospective, randomized comparison to the standard approach. Urology 2012;79:846-51.
[16]	Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS. Recent advances in the diagnosis and treatment of bladder cancer. BMC Med 2013;11:13. http://dx.doi.org/10.1186/1741-7015-11-13.
[17]	Bach T, Muschter R, Herrmann TR, Knoll T, Scoffone CM, Laguna MP, et al. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int 2015;115:14-23.
[18]	Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008;102:1111-4.
[19]	Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q. Narrow band imaging diagnosis of bladder cancer: systematic review and metaanalysis. BJU Int 2012;110:e680-7.
[20]	Li K, Lin T, Fan X, Duan Y, Huang J. Diagnosis of narrow band imaging in non-muscle-invasive bladder cancer: a systemic review and meta-analysis. Int J Urol 2013;20:602-9.
[21]	Ye Z, Hu J, Song X, Li F, Zhao X, Chen S, et al. A comparison of NBI and WLI cystoscopy in detecting non-muscle invasive bladder cancer: a prospective randomized and multicenter study. Sci Rep 2015;5:10905.
[22]	Herr HW. Narrow-band imaging cystoscopy to evaluate the response to bacillie CalmetteeGuerin therapy: the preliminary results. BJU Int 2010;105:314-6.
[23]	Song PH, Cho S, Ko YH. Decision based on narrow band imaging cystoscopy without a referential normal standard rather increases unnecessary biopsy in detection of recurrent bladder urothelial carcinoma early after intravesical instillation. Cancer Res Treat 2016;48:273-80.
[24]	Cauberg EC, Kloen S, Visser M, de la Rosette JJ, Babjuk M, Soukup V, et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology 2010;76:658-63.
[25]	Naselli A, Introini C, Bertolotto F, Spina B, Puppo P. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 2010; 105:208-11.
[26]	Cauberg EC, Mamoulakis C, de la Rosette JJ, de Reijke TM. Narrow band imaging-assisted transurethral resection for nonmuscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 2011;29:503-9.
[27]	Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol 2012;61:908-13.
[28]	Kobatake K, Mita K, Ohara S, Kato M. Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer. Oncol Lett 2015;10:1097-102.
[29]	Jecu M, Geavkere B, Multescu R, Stănescu F, Moldoveanu C, Adou L, et al. NBI cystoscopy in routine urological practice e from better vision to improve therapeutic management. J Med Life 2014;7:282-6.
[30]	Lee JY, Cho KS, Kang DH, Jung HD, Kwon JK, Oh CK, et al. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for nonmuscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer 2015;15:566-75.
[31]	Stănescu F, Geavlete B, Georgescu D, Jecu M, Moldoveanu C, Adou L, et al. NBI-plasma vaporization hybrid approach in bladder cancer endoscopic management. J Med Life 2014;7: 155-9.